367 related articles for article (PubMed ID: 22471524)
1. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
2. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
4. Variation in outpatient mental health service utilization under capitation.
Chou AF; Wallace N; Bloom JR; Hu TW
J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
[TBL] [Abstract][Full Text] [Related]
5. Examination of the effects of financial risk on the formal treatment costs for a Medicaid population with psychiatric disabilities.
Jones K; Chen HJ; Jordan N; Boothroyd RA; Ramoni-Perazzi J; Shern DL
Med Care; 2006 Apr; 44(4):320-7. PubMed ID: 16565632
[TBL] [Abstract][Full Text] [Related]
6. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
9. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
10. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
11. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
Grolleau A; Cougnard A; Bégaud B; Verdoux H
Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Medicaid mental health services by nondisabled children and adolescents.
Buck JA
Psychiatr Serv; 1997 Jan; 48(1):65-70. PubMed ID: 9117502
[TBL] [Abstract][Full Text] [Related]
13. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
[TBL] [Abstract][Full Text] [Related]
15. Impact of a private health insurance mandate on public sector autism service use in Pennsylvania.
Stein BD; Sorbero MJ; Goswami U; Schuster J; Leslie DL
J Am Acad Child Adolesc Psychiatry; 2012 Aug; 51(8):771-9. PubMed ID: 22840548
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization.
Roy AN; Smith M
Sleep Med; 2010 May; 11(5):462-9. PubMed ID: 20363670
[TBL] [Abstract][Full Text] [Related]
18. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
[TBL] [Abstract][Full Text] [Related]
19. Associations between mental health and diabetes: findings from the South Carolina Medicaid managed care program in 2006-2008.
Lòpez-de FA; Hardin JW; Smith KL; Liu Q; Payne T; Stewart JE; Brantley V
Ethn Dis; 2010; 20(3):239-43. PubMed ID: 20828096
[TBL] [Abstract][Full Text] [Related]
20. Medicaid beneficiaries using mental health or substance abuse services in fee-for-service plans in 13 states, 2003.
Ireys HT; Barrett AL; Buck JA; Croghan TW; Au M; Teich JL
Psychiatr Serv; 2010 Sep; 61(9):871-7. PubMed ID: 20810584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
